Stock RDHL REDHILL BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart RedHill Biopharma Ltd.

Equities

RDHL

US7574682024

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
0.4747 USD +3.20% Intraday chart for RedHill Biopharma Ltd. +3.85% -67.49%
May. 06 Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib MT
May. 06 RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
REDHILL BIOPHARMA LTD. Stock RedHill Biopharma Ltd.
 14.66M - - - - -
CSL LIMITED Stock CSL Limited
 89.69B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 41.34B
BIOGEN INC. Stock Biogen Inc.
 33.72B
UCB Stock UCB
 26.11B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 14.63B
  1. Stock Market
  2. Equities
  3. RDHL Stock
  4. Charts RedHill Biopharma Ltd.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW